Biopolymer Nano‐Network for Antimicrobial Peptide Protection and Local Delivery

Antimicrobial resistance (AMR) develops when bacteria no longer respond to conventional antimicrobial treatment. The limited treatment options for resistant infections result in a significantly increased medical burden. Antimicrobial peptides offer advantages for treatment of resistant infections, including broad‐spectrum activity and lower risk of resistance development. However, sensitivity to proteolytic cleavage often limits their clinical application. Here, a moldable and biodegradable colloidal nano‐network is presented that protects bioactive peptides from enzymatic degradation and delivers them locally. An antimicrobial peptide, PA‐13, is encapsulated electrostatically into positively and negatively charged nanoparticles made of chitosan and dextran sulfate without requiring chemical modification. Mixing and concentration of oppositely charged particles form a nano‐network with the rheological properties of a cream or injectable hydrogel. After exposure to proteolytic enzymes, the formed nano‐network loaded with PA‐13 eliminates Pseudomonas aeruginosa during in vitro culture and in an ex vivo porcine skin model while the unencapsulated PA‐13 shows no antibacterial effect. This demonstrates the ability of the nano‐network to protect the antimicrobial peptide in an enzyme‐challenged environment, such as a wound bed. Overall, the nano‐network presents a useful platform for antimicrobial peptide protection and delivery without impacting peptide bioactivity.